---
phase: 162-whole-product-evidence-baseline
plan: 03
subsystem: documentation
tags: [release, support, evidence-audit]
requires:
  - phase: 162-whole-product-evidence-baseline
    provides: feature-owner and operator claim rows from Plan 02
provides:
  - Maintainer, release, security, architecture, performance, and CI claims C-18 through C-24
  - Final 24-row coverage, provenance, source-link, and ordering audit
affects: [phase-163-findings, readiness-evidence]
actuals:
  tokens: 2500
  tasks: 2
  commits: 2
tech-stack:
  added: []
  patterns: [event-triggered freshness, independent evidence limits per row]
key-files:
  created: []
  modified: [162-BASELINE.md, check_baseline.py]
key-decisions:
  - "Preserve exact SHA, selected tuple, advisory lane, package scenario, and version limits on every reused receipt."
  - "Keep all unresolved evidence questions in their claim rows for Phase 163; do not disposition findings or decide readiness here."
requirements-completed: [BASE-01, BASE-02, BASE-03]
coverage:
  - id: D1
    description: "C-18 through C-24 record bounded support, upgrade, publication, security/privacy, architecture, performance, and CI evidence."
    requirement: BASE-02
    verification:
      - kind: other
        ref: "python3 .planning/phases/162-whole-product-evidence-baseline/check_baseline.py --through 24"
        status: pass
    human_judgment: false
  - id: D2
    description: "The final baseline independently covers all seven dimensions, four roles, and seven lifecycle stages with ordered unique claims and resolving local evidence links."
    requirement: BASE-03
    verification:
      - kind: other
        ref: "python3 .planning/phases/162-whole-product-evidence-baseline/check_baseline.py --through 24 --full-coverage"
        status: pass
    human_judgment: false
duration: 4 min
completed: 2026-09-25
status: complete
---

# Phase 162 Plan 03: Maintainer Evidence and Full Audit Summary

**Maintainer and release claims complete the whole-product baseline, with claim-specific provenance, freshness, limits, and downstream evidence questions**

## Performance

- **Duration:** 4 min
- **Started:** 2026-09-25T18:31:38Z
- **Completed:** 2026-09-25T18:35:52Z
- **Tasks:** 2
- **Files modified:** 2

## Accomplishments

- Added C-18 through C-24 for support tuples, upgrade documentation, publication/parity, security/privacy, API consistency, architecture/performance, and CI signal-to-cost.
- Audited all 24 rows for stable IDs, ordering, direct source/result or reasoned absence, provenance, claim boundaries, limitations, assessment, freshness, and invalidators.
- Kept unsupported claims visible as bounded evidence questions; readiness remains the Phase 164 decision.
- Extended the local artifact checker to enforce dimension/lifecycle ordering, reasoned absent proof/results, and full coverage independent of headings.

## Task Commits

1. **Task 1: Assess maintainer support, security, and release claims** — `2e83964` (docs)
2. **Task 2: Audit coverage, provenance, freshness, and downstream handoff** — `5d26f08` (docs)

## Files Created/Modified

- `162-BASELINE.md` — final canonical 24-row evidence index and linked open questions.
- `check_baseline.py` — structural and coverage validation for the index.

## Decisions Made

- Kept exact-SHA, package scenario, compatibility tuple, advisory/required, and release-version evidence within the boundary recorded by its source.
- Routed unsupported evidence questions to Phase 163 without asserting a defect or readiness outcome.

## Deviations from Plan

None - plan executed exactly as written.

## Issues Encountered

The first full coverage check exposed that rows were in claim-ID order rather than the required dimension/lifecycle order. Rows were reordered and the checker now enforces that order. No plan scope or evidence claims changed as a result.

## User Setup Required

None - no external service configuration required.

## Next Phase Readiness

All 24 claims are structurally accounted for, all local Source links resolve, and all approved dimensions, roles, and lifecycle stages are represented. The open evidence questions are ready for Phase 163 triage. No readiness decision is made in this phase.

---
*Phase: 162-whole-product-evidence-baseline*
*Completed: 2026-09-25*
